Literature DB >> 28681342

Response to the letter to the editor by Andreas Sauerbrei on "Acyclovir resistance in herpes simplex type I encephalitis, a case report".

Erich Schmutzhard1, Melanie Bergmann2, Ronny Beer2, Mario Kofler2, Raimund Helbok2, Bettina Pfausler2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28681342     DOI： 10.1007/s13365-017-0539-7

Source DB:  PubMed          Journal:  J Neurovirol        ISSN： 1355-0284            Impact factor:   2.643


× No keyword cloud information.
  4 in total

Review 1.  Herpes simplex virus drug-resistance: new mutations and insights.

Authors:  Graciela Andrei; Robert Snoeck
Journal:  Curr Opin Infect Dis       Date:  2013-12       Impact factor: 4.915

2.  Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients.

Authors:  B Sköldenberg; M Forsgren; K Alestig; T Bergström; L Burman; E Dahlqvist; A Forkman; A Frydén; K Lövgren; K Norlin
Journal:  Lancet       Date:  1984-09-29       Impact factor: 79.321

Review 3.  Management of acyclovir-resistant herpes simplex virus.

Authors:  Suneel Chilukuri; Ted Rosen
Journal:  Dermatol Clin       Date:  2003-04       Impact factor: 3.478

4.  Acyclovir resistance in herpes simplex virus type I encephalitis: a case report.

Authors:  M Bergmann; R Beer; M Kofler; R Helbok; B Pfausler; E Schmutzhard
Journal:  J Neurovirol       Date:  2016-10-27       Impact factor: 2.643
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.